These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17568812)

  • 1. Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes.
    Gelsi-Boyer V; Cervera N; Bertucci F; Trouplin V; Remy V; Olschwang S; Chaffanet M; Vey N; Mozziconacci MJ; Birnbaum D
    Leukemia; 2007 Nov; 21(11):2359-62. PubMed ID: 17568812
    [No Abstract]   [Full Text] [Related]  

  • 2. New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.
    Bou Samra E; Moreaux J; Vacheret F; Mills K; Rufflé F; Chiesa J; Piquemal D; Boureux A; Lavabre-Bertrand T; Jourdan E; Commes T
    Br J Haematol; 2012 May; 157(3):347-56. PubMed ID: 22390678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling in acute lymphoblastic leukemia (ALL).
    Staal FJ
    Lab Hematol; 2004; 10(3):178-81. PubMed ID: 15529443
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
    Chiaretti S; Li X; Gentleman R; Vitale A; Wang KS; Mandelli F; Foà R; Ritz J
    Clin Cancer Res; 2005 Oct; 11(20):7209-19. PubMed ID: 16243790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
    Boultwood J; Perry J; Pellagatti A; Fernandez-Mercado M; Fernandez-Santamaria C; Calasanz MJ; Larrayoz MJ; Garcia-Delgado M; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Hellström-Lindberg E; Cazzola M; Wainscoat JS
    Leukemia; 2010 May; 24(5):1062-5. PubMed ID: 20182461
    [No Abstract]   [Full Text] [Related]  

  • 6. Upregulation of MEL1 and FLJ42875 genes by position effect resulting from a t(1;2)(p36;p21) occurring during evolution of chronic myelomonocytic leukemia.
    Storlazzi CT; Albano F; Guastadisegni MC; Impera L; Mühlematter D; Meyer-Monard S; Wuillemin W; Rocchi M; Jotterand M
    Blood Cells Mol Dis; 2008; 40(3):452-5. PubMed ID: 18178491
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of gene expression signatures for molecular classification in human leukemia cells.
    Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
    Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.
    Hussein K; Büsche G; Muth M; Göhring G; Kreipe H; Bock O
    Ann Hematol; 2011 Mar; 90(3):307-13. PubMed ID: 20842500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
    Oyan AM; Bø TH; Jonassen I; Ulvestad E; Gjertsen BT; Kalland KH; Bruserud O
    Cytometry B Clin Cytom; 2005 Mar; 64(1):18-27. PubMed ID: 15668952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia.
    Johan MF; Goodeve AC; Bowen DT; Frew ME; Reilly JT
    Br J Haematol; 2005 Sep; 130(6):968. PubMed ID: 16156870
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of chronic myelomonocytic leukemia with TP53 mutations.
    Wang W; Routbort MJ; Loghavi S; Tang Z; Medeiros LJ; Wang SA
    Leuk Res; 2018 Jul; 70():97-99. PubMed ID: 29908419
    [No Abstract]   [Full Text] [Related]  

  • 12. The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia.
    Dürig J; Dührsen U; Klein-Hitpass L; Worm J; Hansen JB; Ørum H; Wissenbach M
    Leukemia; 2011 Apr; 25(4):638-47. PubMed ID: 21358717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC is not overexpressed in a case of chronic myelomonocytic leukemia with MYC-containing double minutes.
    Paulsson K; Lassen C; Kuric N; Billström R; Fioretos T; Tanke HJ; Johansson B
    Leukemia; 2003 Apr; 17(4):813-5. PubMed ID: 12682646
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
    Andersson A; Edén P; Lindgren D; Nilsson J; Lassen C; Heldrup J; Fontes M; Borg A; Mitelman F; Johansson B; Höglund M; Fioretos T
    Leukemia; 2005 Jun; 19(6):1042-50. PubMed ID: 15843827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia.
    Chen W; Huang Q
    Leuk Res; 2009 Nov; 33(11):e207-9. PubMed ID: 19540590
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
    Verhaak RG; Wouters BJ; Erpelinck CA; Abbas S; Beverloo HB; Lugthart S; Löwenberg B; Delwel R; Valk PJ
    Haematologica; 2009 Jan; 94(1):131-4. PubMed ID: 18838472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic myelomonocytic leukemia].
    Kalnberza GK; Rotsena AIa; Bondare DK; Teĭlane IIa; Grant KhIa
    Ter Arkh; 1988; 60(11):120-3. PubMed ID: 3238562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia.
    Kosmider O; Itzykson R; Chesnais V; Lasho T; Laborde R; Knudson R; Gauthier A; Merlevede J; Ades L; Morabito M; Fontenay M; Tefferi A; Droin N; Solary E
    Leukemia; 2013 Sep; 27(9):1946-9. PubMed ID: 23774674
    [No Abstract]   [Full Text] [Related]  

  • 20. p53 Protein expression in chronic myelomonocytic leukemia-1 correlates with progression to leukemia and a poor prognosis.
    Hattori N; Fukuchi K; Nakamaki T; Homma M; Ariizumi H; Nakashima H; Maeda T; Saito B; Yamochi-Onizuka T; Yanagisawa K; Matsuda I; Ota H; Tomoyasu S
    Acta Haematol; 2011; 125(4):242-6. PubMed ID: 21335959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.